Dexcom Inc (DXCM) - News Archive

Dexcom G7 Continuous Glucose Monitoring System Launch and New Initiatives for College Athletes with DiabetesIn a significant stride toward enhancing diabetes management, DexCom, Inc. (NASDAQ: DXCM), the global leader in...

In a significant legal development, the Portnoy Law Firm has announced a class-action lawsuit against DexCom, Inc., a prominent player in the continuous glucose monitoring industry. The announcement, made on November 6,...

Investor Alert: DexCom, Inc. Faces Class Action Lawsuits Amid Allegations of Misleading Statements and Unauthorized Device ModificationsDexCom, Inc. (NASDAQ: DXCM), a leader in continuous glucose monitoring systems, is...

Dexcom Unveils Revolutionary Glucose Biosensing Innovations and Clinical Achievements at EASD 2025DexCom, Inc. (Nasdaq: DXCM), the leading innovator in glucose biosensing technology, is set to make significant strides a...

In an impressive display of corporate social responsibility combined with innovative marketing, Dexcom, Inc. (NASDAQ: DXCM) has announced the launch of Season 4 of its unique Name, Image and Likeness (NIL) program Dexco...

Dexcom Poised to Share Strategic Insights at J.P. Morgan Healthcare Conference In January 2025, the global leader in continuous glucose monitoring, Dexcom, Inc. (NASDAQ: DXCM), is set to partake in the 43rd annual J.P....

Dexcom and Oura Join Forces to Revolutionize Metabolic Health MonitoringIn a significant advancement for health technology, DexCom, Inc. (NASDAQ: DXCM), recognized as the global leader in glucose biosensing, and Oura, t...

DexCom Faces Class Action Lawsuit: Investors Urged to Act Before October 21, 2024 DeadlineIn recent developments concerning DexCom, Inc. (NASDAQ: DXCM), a class action securities lawsuit has been filed against the diabe...

In the grand tapestry of financial transactions, where fortunes are often made and lost, it has come to the attention of discerning investors that the reputable Rosen Law Firm, a stalwart of the legal realm, has extende...

Legal Storm Clouds Gather Over DexCom: What Investors Need to Know In recent weeks, DexCom, Inc. (NASDAQ: DXCM) has found itself embroiled in a swirl of legal challenges that have investors on edge. Prominent law firms...

SAN DIEGO DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, is propelling its pioneering initiative, Dexcom U, into its third season. This announce...

Understanding the DexCom Situation: Investor s Rights and Legal ActionsThe legal landscape surrounding DexCom, Inc. (NASDAQ: DXCM) has taken a significant turn, as Rosen Law Firm, a global authority in investor rights,...

In a pioneering leap for both space exploration and healthcare technology, the Polaris Dawn mission has taken to the stars with an eye not just on the cosmos, but also on human health while navigating the challenges of...

The Transformative Role of Continuous Glucose Monitoring in Diabetes Management In the rapidly evolving landscape of diabetes management, DexCom, Inc. emerges as a pivotal player, showcasing its real-time continuous glu...

Class Action Storm Hits DexCom, Stellantis, Symbotic, and NANO Nuclear Energy: What Shareholders Need to KnowAs the financial landscape evolves, so do the complexities and challenges faced by shareholders and investors....

In a milestone moment for diabetes management, Dexcom, Inc. has launched Stelo, the first over-the-counter glucose biosensor in the United States. This groundbreaking development positions Dexcom as a frontrunner in the...

In a significant development for diabetes care in Quebec, Dexcom, Inc. (NASDAQ: DXCM), a leading innovator in real-time continuous glucose monitoring (rtCGM), has announced that its next-generation Dexcom G7 Continuous...

Dexcom Expands AID Partnership Into The Netherlands: Introducing the Omnipod 5 and Dexcom G6 for Easier Diabetes ManagementEDINBURGH, Scotland - DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous gluco...

Dexcom Expands Technological Innovations and Coverage for Diabetes Management: A Strategic Move Towards a Healthier Future Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM)...

Nova Scotia Expands Coverage for Dexcom Continuous Glucose Monitoring Systems as Dexcom Launches New Sensor and Releases Alarming Type 2 Diabetes ReportResidents of Nova Scotia with type 1 or type 2 diabetes who use int...